206 related articles for article (PubMed ID: 30079731)
1. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
Münster-Müller S; Zimmermann R; Pütz M
Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
[TBL] [Abstract][Full Text] [Related]
2. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
[TBL] [Abstract][Full Text] [Related]
3. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
[TBL] [Abstract][Full Text] [Related]
4. Combination of stable isotope ratio data and chromatographic impurity signatures as a comprehensive concept for the profiling of highly prevalent synthetic cannabinoids and their precursors.
Münster-Müller S; Scheid N; Zimmermann R; Pütz M
Anal Chim Acta; 2020 Apr; 1108():129-141. PubMed ID: 32222234
[TBL] [Abstract][Full Text] [Related]
5. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
6. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
Bäckberg M; Tworek L; Beck O; Helander A
J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
[TBL] [Abstract][Full Text] [Related]
7. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA.
Adamowicz P
Forensic Sci Int; 2016 Apr; 261():e5-10. PubMed ID: 26934903
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MS
Mardal M; Dalsgaard PW; Qi B; Mollerup CB; Annaert P; Linnet K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():189-197. PubMed ID: 29549742
[TBL] [Abstract][Full Text] [Related]
9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
10. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
Haden M; Archer JR; Dargan PI; Wood DM
Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
[TBL] [Abstract][Full Text] [Related]
11. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography-Ion Trap Mass Spectrometry Using a Simplified User Interface.
Musile G; Palacio C; Murari M; Appolonova S; Tagliaro F
J Anal Toxicol; 2023 Feb; 47(1):72-80. PubMed ID: 35536611
[TBL] [Abstract][Full Text] [Related]
13. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
[TBL] [Abstract][Full Text] [Related]
14. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
Liu C; Jia W; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
[TBL] [Abstract][Full Text] [Related]
15. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
16. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
[TBL] [Abstract][Full Text] [Related]
17. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
[TBL] [Abstract][Full Text] [Related]
18. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
19. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
[TBL] [Abstract][Full Text] [Related]
20. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
